Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Hoarding Shares Of These Large-Caps

Page 1 of 2

With the latest round of 13F filings in the books, hedge funds’ moves relating to different stocks and sectors during the second quarter are now available to those with the data at their disposal. Instead of just presenting the raw data, Insider Monkey further analyzes different trends exhibited by these elite funds during the period. In some of our previous articles, we’ve looked into hedge funds’ most popular stocks, among others, providing great insight for existing or aspiring investors. In this article, we look at some of the large-cap stocks whose shares are being hoarded by hedge funds. These are Air Products & Chemicals, Inc. (NYSE:APD), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), JD.Com Inc(ADR) (NASDAQ:JD), Williams Companies Inc (NYSE:WMB), and Liberty Global plc – Class C Ordinary Shares (NASDAQ:LBTYK).

Air Products and Chemicals APD

SpaceKris /

We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 118% since then and outperformed the S&P 500 Index by around 60 percentage points (see the details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

First, let’s have a look at Air Products & Chemicals, Inc. (NYSE:APD), the Allentown, Pennsylvania-based supplier of chemicals and gases for industrial uses. The funds tracked by Insider Monkey that were invested in the stock at the end of the second quarter owned 29.40% of the company’s common stock, more than they did of any other large-cap company. Out of the funds that we track, only two out of the top ten shareholders of the stock reduced their positions. In aggregate, however, the number of funds that were invested in the stock was reduced to 76 from 83. The same was seen in the aggregate value of their investments, dropping by 13.07% to $8.64 billion. During the second quarter, the shares of Air Products & Chemicals, Inc. (NYSE:APD) lost 5.85%. The company recently reported better-than-expected earnings and has provided optimistic guidance for the current quarter, owing to its measures to cut down on costs, which included cutting jobs. At the end of the second quarter, Pershing Square, led by billionaire Bill Ackman, was one of the funds that chose to hoard shares of the company, 20.55 million of them in all, valued at $2.81 billion at the end of the quarter.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is another large-cap stock whose shares many hedge funds in our database held at the end of the second quarter. Although a few hedge funds sold their positions in the stock, many funds increased their stakes. At the end of the second quarter, a total of 98 hedge funds we track were invested in the stock, down from 104 at the end of the first quarter. The 98 hedge funds held 29.10% of the company’s common stock at the end of the second quarter. In spite of the drop in hedge fund owners, aggregate investment value was up to $22.02 billion, an increase of $1.91 billion. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) recently announced a plan to acquire Sprout Pharmaceuticals Inc through one of its subsidiaries. If it goes through, the acquisition will be a great addition to Valeant’s portfolio, coming at a time when the U.S. Food and Drug Administration (FDA) has now approved Sprout’s New Drug Application (NDA) for Addyi, which is used for boosting libido. At the end of the second quarter, billionaire Ackman’s Pershing Square was again the biggest shareholder out of the funds we track. It held a stake of 19.47 million shares valued at $4.33 billion. Other notable shareholders  include Jeffrey Ubben‘s ValueAct Capital and John Paulson’s Paulson & Co.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!